Cover:
-GLP-1 drugs are evolving from blockbuster obesity treatments into what could become the pharmaceutical industry's equivalent of AI: a platform technology with expanding applications across dozens of diseases. Barron's argues that Eli Lilly has overtaken Novo Nordisk as the market leader and could double annual profits to more than $60B by 2030, placing it alongside Wall Street's biggest earners. The investment case extends well beyond weight loss, with clinical trials targeting heart disease, Alzheimer's, Parkinson's, kidney disease, addiction and cancer prevention, while expanding Medicare coverage and new delivery methods could dramatically enlarge the addressable market.
CEO Interview:
-No update
Tech Trader:
-This week's violent selloff in AI stocks, triggered by the collapse of highly leveraged hedge fund positions, did little to alter the industry's underlying fundamentals. Barron's argues that earnings from Alphabet, Amazon, and Microsoft demonstrate that massive AI infrastructure spending is already translating into accelerating cloud revenue, expanding margins and stronger pricing power, justifying continued investment of roughly $600B in AI data centers this year. The report also highlights improving adoption of AI software such as Microsoft 365 Copilot and Salesforce Agentforce, while identifying Meta as the only major AI spender lacking a cloud business capable of directly monetizing its enormous capital expenditures.
The Trader:
-Conventional wisdom holds that stocks always outperform bonds over the long run, but new research challenges that assumption. Citing a study by Santa Clara University's Edward McQuarrie, Barron's argues that long-term government bonds have historically outperformed equities during prolonged periods of deflation and disinflation, while stocks have delivered superior returns in inflationary environments. The findings suggest that the equity risk premium is not constant but depends heavily on the prevailing inflation regime, highlighting the importance of macroeconomic conditions in long-term asset allocation.
-Airbnb is trying to evolve from a home-sharing platform into a broad travel-services marketplace offering hotels, experiences, rentals and other services, but Barron's argues the strategy doesn't yet justify the stock's premium valuation. While the company's core business remains healthy and could receive a temporary boost from World Cup travel, increasing regulatory restrictions on short-term rentals and the uncertainty surrounding its expansion into new business lines make the shares look fully valued relative to rivals Booking Holdings and Expedia.
Features:
-Publicis Groupe has transformed itself from a traditional advertising agency into an AI-driven marketing and data company, positioning it to benefit from the growing complexity of digital advertising. Barron's argues the French group has successfully integrated creative services, consumer data and AI-powered media planning, allowing it to outperform peers and raise guidance again. With AI-related services now generating 87% of revenue and demand driven by increasingly fragmented media consumption, the magazine believes the shares could appreciate as much as 56% over the next year.
-Markets are no longer reacting to bad news so much as questioning the assumptions that have driven the bull market for the past three years. Barron's argues that uncertainty over AI spending, the economic outlook and the direction of interest rates has left investors struggling to price risk, triggering a rotation out of semiconductor stocks and into defensive sectors. Despite the shift in sentiment, corporate earnings remain exceptionally strong, with technology still expected to generate roughly half of S&P 500 profits, meaning the market's fate continues to hinge on whether AI investment can justify its enormous cost.
European Trader:
-The Bank of England kept interest rates unchanged at 3.75%, reinforcing the growing divergence between the U.K. and the United States as investors speculated the Federal Reserve might resume tightening. Barron's argues that easing British inflation has given policymakers room to remain on hold despite higher energy prices linked to Middle East tensions. The decision also buys time for new Prime Minister Andy Burnham, whose economic agenda will be closely scrutinized by bond markets wary of increased government spending.
Emerging Markets:
-Chevron delivered blockbuster second-quarter results as higher oil prices during the Iran war and record refinery output drove earnings well above expectations. Barron's argues the company is using the windfall to strengthen its balance sheet rather than aggressively expanding, reducing net debt, integrating its Hess acquisition ahead of schedule and maintaining capital discipline. Despite a sharp rally in the shares, analysts believe Chevron still trades at an unjustified discount to Exxon Mobil, leaving room for further upside.
Commodities:
-International Paper surged after announcing an $80-per-ton increase in containerboard prices, following a similar move by rival Packaging Corp. of America, reinforcing signs of stronger pricing power across the packaging industry. Barron's says the increase reflects higher input costs, tight supply and resilient demand, while J.P. Morgan upgraded the stock, arguing that improving industry fundamentals and higher prices should support earnings despite the shares' recent rally.
Streetwise:
-No update